Categories: AFRICABusiness

South Africa’s Aspen agrees with J&J to Manufacture COVID-19 Vaccine

South African pharmaceutical company Aspen Pharmacare said on Monday it had entered into a preliminary agreement with Johnson & Johnson to commercially manufacture its COVID-19 vaccine candidate.

Aspen said it had agreed to provide capacity required for the manufacture of J&J’s vaccine candidate, which is still undergoing clinical trials, at its Port Elizabeth facility.

Aspen will perform formulation, filling and secondary packaging of the vaccine for supply to Johnson & Johnson, the company said.

Follow us on:

AriseNews

Recent Posts

Anambra Lacks Regulatory Framework For Crowd Control, Says Information Commissioner Law Mefor

Anambra lacks formal crowd control law but is working on a regulatory framework, says state…

1 hour ago

Akugbe Iyamu: We Must Be Prepared For Severe Droughts, Hunger in 2025

Retired Air Vice Marshal Akugbe Iyamu has called for urgent preparations for drought, heatwaves, and…

2 hours ago

Romania Set To Form New Government With Marcel Ciolacu As Prime Minister

Romania's president Klaus Iohannis is expected to designate Prime Minister Marcel Ciolacu to form a…

2 hours ago

Nigeria Announces Public Holidays for Christmas and New Year Celebrations

Federal Government of Nigeria has declared public holidays to mark Christmas and New Year festivities…

2 hours ago

IGP Orders Investigation into Death of Ilorin Detainee Jimoh Abdulquadri in Police Custody

IGP Egbetokun has ordered an investigation into Jimoh Abdulquadri’s death in police custody, promising justice…

6 hours ago

Trump Dismisses Claims That Elon Musk Holds Real Power Behind US President-Elect

Donald Trump has rejected suggestions that Elon Musk is the true influence behind the newly…

6 hours ago